Roche gets EU nod for Evrysdi's expanded label in spinal muscular atrophy

1 day ago 1
SMA, spinal muscular atrophy, Written on wooden blocks, a rare disease in which, due to a genetic defect, neurons in the spinal cord responsible for muscle contraction and relaxation gradually die.

Andrzej Rostek

  • Roche (OTCQX:RHHBY) (OTCQX:RHHBF) said on Wednesday that the European Commission has approved a new tablet form of Evrysdi for those affected by spinal muscular atrophy.
  • The Evrysdi 5 mg tablet is designed to be taken with or without food and

Recommended For You

More Trending News

Read Entire Article